SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID19 vaccine shot as a trigger? Comment on :Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150

Simon Cadiou (1) , Aleth Perdriger (1) , Samuel Ardois (1) , Jean-David Albert (2, 1) , Olivia Berthoud (1) , Alain Lescoat (3, 4, 1) , Pascal Guggenbuhl (2, 1) , François Robin (2, 1)

1 Centre Hospitalier Universitaire [Rennes]
2 NuMeCan - Nutrition, Métabolismes et Cancer
3 Irset - Institut de recherche en santé, environnement et travail
4 EHESP - École des Hautes Études en Santé Publique [EHESP]

Mots clés: vaccine; polymyalgia rheumatic; giant cell arteritis; SARS-CoV-2; COVID19

Domaines: Sciences du Vivant [q-bio]

Simon Cadiou, Aleth Perdriger, Samuel Ardois, Jean-David Albert, Olivia Berthoud, et al.. SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID19 vaccine shot as a trigger? Comment on :Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150. Joint Bone Spine, 2022, 89 (1), pp.105282. ⟨10.1016/j.jbspin.2021.105282⟩. ⟨hal-03368354⟩